Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies.
about
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyImmunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathyImmunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathyImmunosuppressant and immunomodulatory treatments for multifocal motor neuropathyIntravenous immunoglobulin for multifocal motor neuropathyComparison of the effects of low dose interferon and high dose interferon on reduction of the number and size of plaques in patients with Multiple Sclerosis: A historical cohort.Diagnosis of motor neuropathy.Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study.Recent studies on the roles of antiglycosphingolipids in the pathogenesis of neurological disorders.Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Evidence-based treatment of chronic immune-mediated neuropathies.Treatment in inflammatory neuropathies.Immunotherapy of multifocal motor neuropathy.Multifocal motor neuropathy: current therapies and novel strategies.Outcome measures in MMN revisited: further improvement needed.Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.Diagnostic spectrum of multifocal motor neuropathy
P2860
Q24187418-58FD139D-60B5-41A8-B14D-7417BED4F5A7Q24200228-E325DA22-A58D-4F2A-AFD8-54953B8DF5F0Q24201954-493E005F-4F16-4D41-8CDC-68036DE44FE4Q24236599-F4A39E4F-32D5-4469-8AD7-79FFCBAA510AQ24241391-E36C43D9-F443-4AD0-96D4-DE968B8217D8Q24247007-5DCED52C-D22B-43B3-9A3A-BE4210113B66Q33896802-CB0F60BB-08BE-4AF1-8E5F-ECE63BC43E5EQ34235867-4977EA3C-38B2-4034-8B45-1FB8622A0A5BQ34330842-7536640B-7BF5-40D7-A65A-99C8C16EEA4FQ34356146-FBC72316-3831-4D0C-B277-C5F88489614DQ36365583-8598B91F-1808-47A9-A8AB-100E4A6327BAQ37550515-AF4BD973-DFCC-4B59-B3D2-FCDDC8F5A587Q37733512-1D618124-AD8C-4DD7-B77D-88C337EF95D2Q37836898-2A09968A-0D81-485B-84FB-D4F33EC9743BQ38091664-480D7732-8F33-4D82-A812-9DCBCAF72E88Q40793045-D37154E5-3686-4140-9E06-A85D68831635Q49125609-F4CA8983-B770-469D-B35E-D32BA73754D7Q56771736-CEB91243-ACCF-4700-8152-D3010C118918
P2860
Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies.
description
1999 nî lūn-bûn
@nan
1999 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Chronic motor neuropathies: re ...... ure of conventional therapies.
@ast
Chronic motor neuropathies: re ...... ure of conventional therapies.
@en
type
label
Chronic motor neuropathies: re ...... ure of conventional therapies.
@ast
Chronic motor neuropathies: re ...... ure of conventional therapies.
@en
prefLabel
Chronic motor neuropathies: re ...... ure of conventional therapies.
@ast
Chronic motor neuropathies: re ...... ure of conventional therapies.
@en
P2093
P2860
P356
P1476
Chronic motor neuropathies: re ...... ure of conventional therapies.
@en
P2093
Martina IS
Meulstee J
Schmitz PI
van Doorn PA
P2860
P304
P356
10.1136/JNNP.66.2.197
P407
P577
1999-02-01T00:00:00Z